Individualized Risk Assessment in Neuroblastoma: Does The Tumoral Metabolic Activity in I-123-MIBG-SPECT Predict the Outcome?J. Rogasch,P. Hundsdoerfer,C. Furth, F. Wedel,F. Hofheinz, P. C. Krueger,H. Lode,W. Brenner,A. Eggert,H. Amthauer,I. SchatkaPEDIATRIC BLOOD & CANCER(2017)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要